A phase I trial of hypoxoside as an oral prodrug for cancer therapy - absence oftoxicity

Authors
Publication date
14 December 2016
Publisher
Health and Medical Publishing Group

Abstract

No Abstract

    Similar works

    Full text

    thumbnail-image

    Available Versions

    AJOL - African Journals Online

    redirect
    oaioai:ajol.info:article/149568
    Last time updated on 06/10/2021